357 related articles for article (PubMed ID: 27495782)
1. Integrative analysis of metabolome and gut microbiota in diet-induced hyperlipidemic rats treated with berberine compounds.
Li M; Shu X; Xu H; Zhang C; Yang L; Zhang L; Ji G
J Transl Med; 2016 Aug; 14(1):237. PubMed ID: 27495782
[TBL] [Abstract][Full Text] [Related]
2. Akebia Saponin D Regulates the Metabolome and Intestinal Microbiota in High Fat Diet-Induced Hyperlipidemic Rats.
Zhou P; Yang X; Yang Z; Huang W; Kou J; Li F
Molecules; 2019 Apr; 24(7):. PubMed ID: 30939835
[TBL] [Abstract][Full Text] [Related]
3. Feces and liver tissue metabonomics studies on the regulatory effect of aspirin eugenol eater in hyperlipidemic rats.
Ma N; Liu X; Kong X; Li S; Jiao Z; Qin Z; Dong P; Yang Y; Li J
Lipids Health Dis; 2017 Dec; 16(1):240. PubMed ID: 29228968
[TBL] [Abstract][Full Text] [Related]
4. Combination of berberine and evodiamine inhibits intestinal cholesterol absorption in high fat diet induced hyperlipidemic rats.
Zhou X; Ren F; Wei H; Liu L; Shen T; Xu S; Wei J; Ren J; Ni H
Lipids Health Dis; 2017 Dec; 16(1):239. PubMed ID: 29228954
[TBL] [Abstract][Full Text] [Related]
5. The berberine-enriched gut commensal Blautia producta ameliorates high-fat diet (HFD)-induced hyperlipidemia and stimulates liver LDLR expression.
Yang YN; Wang QC; Xu W; Yu J; Zhang H; Wu C
Biomed Pharmacother; 2022 Nov; 155():113749. PubMed ID: 36174380
[TBL] [Abstract][Full Text] [Related]
6. Dietary quinoa (Chenopodium quinoa Willd.) polysaccharides ameliorate high-fat diet-induced hyperlipidemia and modulate gut microbiota.
Cao Y; Zou L; Li W; Song Y; Zhao G; Hu Y
Int J Biol Macromol; 2020 Nov; 163():55-65. PubMed ID: 32615219
[TBL] [Abstract][Full Text] [Related]
7. Ganoderic acid A from Ganoderma lucidum ameliorates lipid metabolism and alters gut microbiota composition in hyperlipidemic mice fed a high-fat diet.
Guo WL; Guo JB; Liu BY; Lu JQ; Chen M; Liu B; Bai WD; Rao PF; Ni L; Lv XC
Food Funct; 2020 Aug; 11(8):6818-6833. PubMed ID: 32686808
[TBL] [Abstract][Full Text] [Related]
8. UPLC/Q-TOF-MS/MS-based metabolomics revealed the lipid-lowering effect of Ilicis Rotundae Cortex on high-fat diet induced hyperlipidemia rats.
Yang B; Xuan S; Ruan Q; Jiang S; Cui H; Zhu L; Luo X; Jin J; Zhao Z
J Ethnopharmacol; 2020 Jun; 256():112784. PubMed ID: 32222573
[TBL] [Abstract][Full Text] [Related]
9. Gut microbiota combined with metabolomics reveals the metabolic profile of the normal aging process and the anti-aging effect of FuFang Zhenshu TiaoZhi(FTZ) in mice.
Luo D; Chen K; Li J; Fang Z; Pang H; Yin Y; Rong X; Guo J
Biomed Pharmacother; 2020 Jan; 121():109550. PubMed ID: 31704617
[TBL] [Abstract][Full Text] [Related]
10. Berberine compounds improves hyperglycemia via microbiome mediated colonic TGR5-GLP pathway in db/db mice.
Li M; Zhou W; Dang Y; Li C; Ji G; Zhang L
Biomed Pharmacother; 2020 Dec; 132():110953. PubMed ID: 33254441
[TBL] [Abstract][Full Text] [Related]
11. A plasma metabonomics study on the therapeutic effects of the Si-miao-yong-an decoction in hyperlipidemic rats.
Shi S; Liu Z; Xue Z; Chen X; Chu Y
J Ethnopharmacol; 2020 Jun; 256():112780. PubMed ID: 32222575
[TBL] [Abstract][Full Text] [Related]
12. Modulation of gut microbiota by berberine and metformin during the treatment of high-fat diet-induced obesity in rats.
Zhang X; Zhao Y; Xu J; Xue Z; Zhang M; Pang X; Zhang X; Zhao L
Sci Rep; 2015 Sep; 5():14405. PubMed ID: 26396057
[TBL] [Abstract][Full Text] [Related]
13. Effect of Berberine on promoting the excretion of cholesterol in high-fat diet-induced hyperlipidemic hamsters.
Li XY; Zhao ZX; Huang M; Feng R; He CY; Ma C; Luo SH; Fu J; Wen BY; Ren L; Shou JW; Guo F; Chen Y; Gao X; Wang Y; Jiang JD
J Transl Med; 2015 Aug; 13():278. PubMed ID: 26310319
[TBL] [Abstract][Full Text] [Related]
14. Beneficial Metabolic Effects of 2',3',5'-Triacetyl-N
Li T; Sun S; Zhang J; Qu K; Yang L; Ma C; Jin X; Zhu H; Wang Y
J Proteome Res; 2018 Aug; 17(8):2870-2879. PubMed ID: 29925242
[TBL] [Abstract][Full Text] [Related]
15. A metabolomic and pharmacokinetic study on the mechanism underlying the lipid-lowering effect of orally administered berberine.
Gu S; Cao B; Sun R; Tang Y; Paletta JL; Wu X; Liu L; Zha W; Zhao C; Li Y; Ridlon JM; Hylemon PB; Zhou H; Aa J; Wang G
Mol Biosyst; 2015 Feb; 11(2):463-74. PubMed ID: 25411028
[TBL] [Abstract][Full Text] [Related]
16. The pandanus tectorius fruit extract (PTF) modulates the gut microbiota and exerts anti-hyperlipidaemic effects.
Wu C; Tian Y; Yu J; Zhang R; Zhang X; Guo P
Phytomedicine; 2019 May; 58():152863. PubMed ID: 30836215
[TBL] [Abstract][Full Text] [Related]
17. Gut microbiota specifically mediates the anti-hypercholesterolemic effect of berberine (BBR) and facilitates to predict BBR's cholesterol-decreasing efficacy in patients.
Wu C; Zhao Y; Zhang Y; Yang Y; Su W; Yang Y; Sun L; Zhang F; Yu J; Wang Y; Guo P; Zhu B; Wu S
J Adv Res; 2022 Mar; 37():197-208. PubMed ID: 35499044
[TBL] [Abstract][Full Text] [Related]
18. Chronic effects of berberine on blood, liver glucolipid metabolism and liver PPARs expression in diabetic hyperlipidemic rats.
Zhou JY; Zhou SW; Zhang KB; Tang JL; Guang LX; Ying Y; Xu Y; Zhang L; Li DD
Biol Pharm Bull; 2008 Jun; 31(6):1169-76. PubMed ID: 18520050
[TBL] [Abstract][Full Text] [Related]
19. Structural changes of gut microbiota during berberine-mediated prevention of obesity and insulin resistance in high-fat diet-fed rats.
Zhang X; Zhao Y; Zhang M; Pang X; Xu J; Kang C; Li M; Zhang C; Zhang Z; Zhang Y; Li X; Ning G; Zhao L
PLoS One; 2012; 7(8):e42529. PubMed ID: 22880019
[TBL] [Abstract][Full Text] [Related]
20. Variations in gut microbiota and fecal metabolic phenotype associated with depression by 16S rRNA gene sequencing and LC/MS-based metabolomics.
Yu M; Jia H; Zhou C; Yang Y; Zhao Y; Yang M; Zou Z
J Pharm Biomed Anal; 2017 May; 138():231-239. PubMed ID: 28219800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
